-
Women with MS Using Rebif Are Not at Higher Risk of Miscarriage or Ectopic Pregnancy
A large observational study found no increased risk of miscarriage or ectopic pregnancy in women with MS who were being treated with Rebif during the first trimester. Read the full story here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.